Currently, Apogee Therapeutics Inc [APGE] is trading at $48.38, down -1.41%. An important factor to consider is whether the stock is rising or falling in short-term value. The APGE shares have gain 4.58% over the last week, with a monthly amount drifted -20.84%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Apogee Therapeutics Inc [NASDAQ: APGE] stock has seen the most recent analyst activity on November 25, 2024, when Canaccord Genuity initiated its Buy rating and assigned the stock a price target of $89. Previously, BofA Securities started tracking the stock with Buy rating on May 10, 2024, and set its price target to $80. On December 20, 2023, BTIG Research initiated with a Buy rating and assigned a price target of $43 on the stock. Wedbush started tracking the stock assigning a Outperform rating and suggested a price target of $40 on August 08, 2023. TD Cowen initiated its recommendation with a Outperform. Stifel started tracking with a Buy rating for this stock on August 08, 2023, and assigned it a price target of $34. In a note dated August 08, 2023, Jefferies initiated an Buy rating and provided a target price of $29 on this stock.
This stock has fluctuated between a low of $19.91 and a high of $72.29 over the last 52 weeks. Currently, Wall Street analysts expect the stock to reach $95 within the next 12 months. Apogee Therapeutics Inc [NASDAQ: APGE] shares were valued at $48.38 at the most recent close of the market. An investor can expect a potential return of 96.36% based on the average APGE price forecast.
Analyzing the APGE fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.19, Equity is -0.22 and Total Capital is -0.24.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 47.67 points at the first support level, and at 46.97 for the second support level. However, for the 1st resistance point, the stock is sitting at 49.36, and for the 2nd resistance point, it is at 50.34.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Apogee Therapeutics Inc [NASDAQ:APGE] is 16.39. On the other hand, the Quick Ratio is 16.39, and the Cash Ratio is 3.64.
Transactions by insiders
Recent insider trading involved Dambkowski Carl, Chief Medical Officer, that happened on Dec 04 ’24 when 6665.0 shares were sold. Chief Executive Officer, HENDERSON MICHAEL THOMAS completed a deal on Dec 04 ’24 to sell 15000.0 shares. Meanwhile, Officer HENDERSON MICHAEL THOMAS bought 15000.0 shares on Dec 04 ’24.
